Allergy Therapeutics
BalancedAGY·XLON·🇬🇧 GB
50%buys·50%sales
8 transactions$0Total buys·0 buys
$0Total sells·0 sells
22 insiders
Last: Feb 25, 2026
companyInsight.narrative_dormancy
Allergy Therapeutics (AGY) has recorded 8 insider operations, including 0 open-market purchases ($0), 0 sales ($0) and 8 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Advanced analytics coming soon
Price impact analysis, win rates, and predictive signals are being developed.